<img alt="" src="https://secure.wake4tidy.com/244317.png" style="display:none;">

​Planing for and responding to the Coronavirus - Vironova remains operational

Our commitment during the Covid-19 outbreak -  Control the controllables. Which in short can be summarized by: Ensure the health and safety of our employees. Enabling business by remote work for employees and remaining operational for our customers.


International Women´s Day

It is not about making women stronger -- women are already strong. It's about changing the way the world perceives that strength.


Video: Seeing is believing - Analytics of data and visualization of information is knowing

  Did you know:  With good and actionable analytics data insights, biopharma companies can make better development decisions early, reduce process development time, and triple the number of projects that can be done in the same timeframe. Pure ROI....


Winter holiday greetings

We at Vironova would like to take the opportunity to wish you an active and relaxing, “sports holiday” - AKA "sportlov" in Swedish. Or actually for the ones having the privilege (because many of us are working) of having a couple of day’s or a...


Real time state tracking of 2019-nCoV AKA the Coronoavirus

Track the 2019-nCoV AKA the Coronoavirus spread in "real-time". World map cases and locations can be viewed, and data available for download.


The world’s first GMP certification for Electron Microscope Lab

Vironova has received the world’s first and only GMP certification for Electron Microscope Lab from Swedish Medical Products Agency


Five questions and answers regarding 2019-nCoV AKA The Coronavirus

With the world attention on the coronavirus outbreak, and as it continous to spread across China and other parts of the world, a flurry of early research is drawing a clearer picture of how the pathogen behaves and the key factors that will...


The latest development in viral and non-viral vector manufacturing

Transmission Electron Microscopy - a Critical Component of the Vector Analytical Toolkit


How do we solve the increased demand for accurate and and fast viral vector analytics?

The need for analytical technology that reveals the effect of production process on CQAs of viral particles in gene therapy and vaccines, and the most common analyses requested.


Our MiniTEM system is now part of Testa Center’s (GE Healthcare subsidiary) analytical toolkit

We at Vironova are delighted to have entered into a collaboration with Testa Center in Uppsala, Sweden! Testa Center is a GE Healthcare subsidiary (GE owns 100%) and a separate business entity running as non-profit and with legal autonomy.